Transparency data
Voluntary scheme aggregate net sales and payment information: February 2021
Information on how the 2019 voluntary scheme for branded medicines pricing and access is controlling spend on branded medicines in the NHS.
Documents
Details
This document sets out the NHS’s quarterly aggregate net sales and payment information on pharmaceuticals for February 2021.
The 2019 voluntary scheme for branded medicines pricing and access is an agreement between DHSC and the Association of the British Pharmaceutical Industry (ABPI) on getting the best value and most effective medicines into use more quickly.
Updates to this page
Published 1 March 2021